SINOVAC BIOTECH LTD Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
SINOVAC BIOTECH LTD (SVA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $83.70 million for the 12-month period ending 2022-12-31, per its 20-F filed 2024-04-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2024-04-29
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2022-12-31 | $83.70M 20-F · filed 2024-04-29 | $12.71M 20-F · filed 2023-05-01 |
| 2021-12-31 | $4.13M 20-F · filed 2022-04-29 | |
| 2020-12-31 | -$2.66M 20-F · filed 2021-04-22 | |
| 2019-12-31 | -$4.94M 20-F · filed 2020-04-30 | |
| 2018-12-31 | -$2.27M 20-F · filed 2019-04-29 |